No evidence for FANCF gene silencing in head-and-neck squamous cell carcinomas

Cellular Oncology

Volumn 31, Issue 1, 2009, Pages 53-56

  Ameziane, Najim ^a   Chen, Fei ^b   Leemans, C René ^a   Brakenhoff, Ruud H ^a   Joenje, Hans ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; DNA; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOSOMAL RECESSIVE INHERITANCE; CANCER SUSCEPTIBILITY; CHROMOSOMAL INSTABILITY; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; DNA ISOLATION; DNA SEQUENCE; FALSE POSITIVE RESULT; FANCONI ANEMIA; GENE FUNCTION; GENE SILENCING; GENETIC PREDISPOSITION; HEAD AND NECK CARCINOMA; HUMAN; LETTER; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DNA METHYLATION; FANCONI ANEMIA COMPLEMENTATION GROUP F PROTEIN; GENE SILENCING; HEAD AND NECK NEOPLASMS; HUMANS;

EID: 58149385508     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2009-0462     Document Type: Letter

References (22)

1. B.P. Alter, Cancer in Fanconi anemia, 1927-2001, Cancer 97 (2003), 425-440.
2. H. Joenje and K.J. Patel, The emerging genetic and molecular basis of Fanconi anaemia, Nat. Rev. Genet. 2 (2001), 446-457.
3. J.C. Dorsman, M. Levitus, D. Rockx, M.A. Rooimans, A.B. Oostra, A. Haitjema, S.T. Bakker, J. Steltenpool, D. Schuler, S. Mohan, D. Schindler, F. Arwert, G. Pals, C.G. Mathew, Q. Waisfisz, J.P. de Winter and H. Joenje, Identification of the Fanconi anemia complementation group I gene, FANCI, Cell. Oncol. 29 (2007), 211-218.
4. M. Levitus, H. Joenje and J.P. de Winter, The Fanconi anemia pathway of genomic maintenance, Cell. Oncol. 28 (2006), 3-29.
5. G.A. Meijer, The 13th Fanconi anemia gene identified: FANCI. Importance of the 'Fanconi anemia pathway' for cellular oncology, Cell. Oncol. 29 (2007), 181-182.
6. W. Wang, Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins, Nat. Rev. Genet. 8 (2007), 735-748.
7. H. Hoehn, K. Neveling, D. Endt, R. Melcher and D. Schindler, Neoplasia, ageing, and genetic instability due to defective caretaker genes, Cell. Oncol. 30 (2008), 461-462.
8. C. Jacquemont and T. Taniguchi, Disruption of the Fanconi anemia pathway in human cancer in the general population, Cancer Biol. Ther. 5 (2006), 1637-1639.
9. C.J. Hess, N. Ameziane, G.J. Schuurhuis, A. Errami, F. Denkers, G.J. Kaspers, J. Cloos, H. Joenje, D. Reinhardt, G.J. Ossenkoppele, C.M. Zwaan and Q. Waisfisz, Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia, Cell. Oncol. 30 (2008), 299-306.
10. M. Tischkowitz, N. Ameziane, Q. Waisfisz, J.P. de Winter, R. Harris, T. Taniguchi, A. D'Andrea, S.V. Hodgson, C.G. Mathew and H. Joenje, Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia, Br. J. Haematol. 123 (2003), 469-471.
11. O.I. Olopade and M. Wei, FANCF methylation contributes to chemoselectivity in ovarian cancer, Cancer Cell 3 (2003), 417-420.
12. M. Wei, J. Xu, J. Dignam, R. Nanda, L. Sveen, J. Fackenthal, T.A. Grushko and O.I. Olopade, Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers, Breast Cancer Res. Treat. 111 (2008), 113-120.
13. V.S. Dhillon, M. Shahid and S.A. Husain, CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin, Mol. Cancer 3 (2004), 33.
14. S.L. Lim, P. Smith, N. Syed, C. Coens, H. Wong, B.M. van der Burg, P. Szlosarek, T. Crook and J.A. Green, Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer, Br. J. Cancer 98 (2008), 1452-1456.
15. T. Taniguchi, M. Tischkowitz, N. Ameziane, S.V. Hodgson, C.G. Mathew, H. Joenje, S.C. Mok and A.D. D'Andrea, Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors, Nat. Med. 9 (2003), 568-574.
16. Z. Wang, M. Li, S. Lu, Y. Zhang and H. Wang, Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway, Cancer Biol. Ther. 5 (2006), 256-260.
17. K. Neveling, R. Kalb, A.R. Florl, S. Herterich, R. Friedl, H. Hoehn, C. Hader, F.H. Hartmann, I. Nanda, C. Steinlein, M. Schmid, H. Tonnies, C.D. Hurst, M.A. Knowles, H. Hanenberg, W.A. Schulz and D. Schindler, Disruption of the FA/BRCA pathway in bladder cancer, Cytogen. Genome Res. 118 (2007), 166-176.
18. G. Narayan, H. Arias-Pulido, S.V. Nandula, K. Basso, D.D. Sugirtharaj, H. Vargas, M. Mansukhani, J. Villella, L. Meyer, A. Schneider, L. Gissmann, M. Durst, B. Pothuri and V.V. Murty, Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer, Cancer Res. 64 (2004), 2994-2997.
19. S. Koul, J.M. McKiernan, G. Narayan, J. Houldsworth, J. Bacik, D.L. Dobrzynski, A.M. Assaad, M. Mansukhani, V.E. Reuter, G.J. Bosl, R.S. Chaganti and V.V. Murty, Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors, Mol. Cancer 3 (2004), 16.
20. C.J. Marsit, M. Liu, H.H. Nelson, M. Posner, M. Suzuki and K.T. Kelsey, Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival, Oncogene 23 (2004), 1000-1004.
21. S. Derks, M.H. Lentjes, D.M. Hellebrekers, A.P. de Bruine, J.G. Herman and E.M. van Engeland, Methylation-specific PCR unraveled, Cell. Oncol. 26 (2004), 291-299.
22. A.O. Nygren, N. Ameziane, H.M. Duarte, R.N. Vijzelaar, Q. Waisfisz, C.J. Hess, J.P. Schouten and A. Errami, Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences, Nucleic Acids Res. 33 (2005), e128.